Back to search

Article

Molecular pathway of influenza pan-neuraminidase inhibitors resistance in an immunocompromised patient

2019-09-16

Abstract excerpt

Neuraminidase (NA) inhibitors (NAIs), including oseltamivir and zanamivir, play an important therapeutic role against influenza infections in immunocompromised patients. In such settings, however, NAI therapy may lead to the emergence of resistance involving mutations within the influenza surface genes. The aim of this study was to investigate the evolution of hemagglutinin (HA) and NA genes of influenza A(H1N1)pd...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
53e120c8-222e-5bbd-8921-1b3693916216
DOI
10.1101/768614
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular pathway of influenza pan-neuraminidase inhibitors resistance in an immunocompromised patientDOI 10.1101/768614
Select a neighboring publication to make it the new centre.